Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Novel Sources of Fetal Stem Cells for Future Regenerative Medicine

The Indonesian Biomedical Journal · Vol. 4 No. 1 (2012) · hlm. 3–3

DOI
10.18585/inabj.v4i1.155
ISSN
2085-3297, 2355-9179
Terbit
2012-04-01
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Mesenchymal stromal cells are multipotent cells considered to be of great promise for use in regenerative medicine. However, the cell dose may be a critical factor in many clinical conditions and the yield resulting from the ex vivo expansion of mesenchymal stromal cells derived from bone marrow may be insufficient. Thus, alternative sources of mesenchymal stromal cells need to be explored.CONTENT: There are multiple extra-embryonic tissues emerging during gestation including umbilical cord blood (UCB), amniotic fluid (AF), Wharton’s jelly, the amniotic membrane and the placenta, which are all discarded following birth. Fetal stem cells from these sources actually represent a new class of stem cells developmentally and operationally located between the state of embryonic stem cells and adult stem cells, sharing and exhibiting features of pluripotency and multipotency, without necessarily implying that they can generate every type of tissue.SUMMARY: Fetal stem cells have been recently isolated from several tissues (amniotic fluid, umbilical cord, Wharton’s jelly, amnion and placenta). They are derived either from the fetus proper or from the supportive extra-embryonic structures. They represent ideal sources for regenerative medicine since they are easily accessible, exhibit high proliferation rates, do not form teratomas and present no ethical reservations like embryonic stem cells (ESC). Their functional features indicate that they actually represent intermediates between ESC and adult stem cells.KEYWORDS: mesenchymal stem cells, fetal stem cells, amniotic fluid, umbilical cord, placenta, wharton’s jelly

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 125 tautan kepenulisan bersama · 56 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Hasanuddin University
  • Padjadjaran University
  • University of Indonesia
  • PT Prodia StemCell Indonesia (Indonesia)
  • Udayana University
  • Universitas Trisakti
  • Universitas Airlangga
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Anna MeilianaPadjadjaran University87
Nurrani Mustika DewiPadjadjaran University45
Suryani As’ádHasanuddin University15
Gatot Susilo LawrenceHasanuddin University9
Cynthia Retna SartikaPT Prodia StemCell Indonesia (Indonesia)5
Ilhamjaya PatellongiHasanuddin University4
Anwar SantosoUdayana University4
Syakib BakriHasanuddin University4
Teguh RanakusumaUniversity of Indonesia3
Irawan YusufHasanuddin University3
Rima HaifaPT Prodia StemCell Indonesia (Indonesia)3
Trilis YuliantiHasanuddin University3
Yenny SurjawanHasanuddin University2
Irma Ruslina DefiPadjadjaran University2
Mansyur AriefHasanuddin University2
Andri HidayatHasanuddin University2
Melisa Intan BarlianaPadjadjaran University2
Keri Lestari DandanPadjadjaran University2
Ferry SandraUniversitas Trisakti2
Ahmad FariedPadjadjaran University2
Keri LestariPadjadjaran University2
Marsetio DonosepoetroUniversitas Airlangga2
Burhanuddin BaharHasanuddin University2
Lucia HerminawatiHasanuddin University2
Widjaja LukitoSEAMEO Regional Center for Food and Nutrition2
Indriyanti Rafi SukmawatiHasanuddin University2
Antonia Anna LukitoHasanuddin University2
Mansyur ArifHasanuddin University2
Candra NinghayuHasanuddin University1
Anna MeilanaPadjadjaran University1
Aziiz Mardanarian RosdiantoPadjadjaran University1
Adziqa Ammara QiantoriPadjadjaran University1
Bachtiar MurtalaHasanuddin University1
Terawan Agus PutrantoGatot Soebroto Army Hospital1
Hera Yuliana IntantriAfiliasi tidak diketahui1
Meily L KurniawidjajaUniversity of Indonesia1
Nuri Purwito AdiUniversity of Indonesia1
Mulyana MulyanaHasanuddin University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Novel Sources of Fetal Stem Cells for Future Regenerative Medicine</dc:title><dc:creator>Yani Lina</dc:creator><dc:creator>Andi Wijaya</dc:creator><dc:subject>fetal stem cells</dc:subject><dc:subject>mesenchymal stem cells</dc:subject><dc:subject>regenerative medicine</dc:subject><dc:subject>amniotic fluid</dc:subject><dc:subject>umbilical cord</dc:subject><dc:subject>Wharton's jelly</dc:subject><dc:subject>amniotic membrane</dc:subject><dc:subject>placenta</dc:subject><dc:subject>extraembryonic tissues</dc:subject><dc:subject>pluripotency</dc:subject><dc:subject>multipotency</dc:subject><dc:subject>alternative stem cell sources</dc:subject><dc:description xml:lang="en">BACKGROUND: Mesenchymal stromal cells are multipotent cells considered to be of great promise for use in regenerative medicine. However, the cell dose may be a critical factor in many clinical conditions and the yield resulting from the ex vivo expansion of mesenchymal stromal cells derived from bone marrow may be insufficient. Thus, alternative sources of mesenchymal stromal cells need to be explored.CONTENT: There are multiple extra-embryonic tissues emerging during gestation including umbilical cord blood (UCB), amniotic fluid (AF), Wharton’s jelly, the amniotic membrane and the placenta, which are all discarded following birth. Fetal stem cells from these sources actually represent a new class of stem cells developmentally and operationally located between the state of embryonic stem cells and adult stem cells, sharing and exhibiting features of pluripotency and multipotency, without necessarily implying that they can generate every type of tissue.SUMMARY: Fetal stem cells have been recently isolated from several tissues (amniotic fluid, umbilical cord, Wharton’s jelly, amnion and placenta). They are derived either from the fetus proper or from the supportive extra-embryonic structures. They represent ideal sources for regenerative medicine since they are easily accessible, exhibit high proliferation rates, do not form teratomas and present no ethical reservations like embryonic stem cells (ESC). Their functional features indicate that they actually represent intermediates between ESC and adult stem cells.KEYWORDS: mesenchymal stem cells, fetal stem cells, amniotic fluid, umbilical cord, placenta, wharton’s jelly</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2012-04-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v4i1.155</dc:identifier><dc:identifier>10.18585/inabj.v4i1.155</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 4 No 1 (2012); 3-3</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/155/184</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>